Impact of Timing of Premedication on Mucosal Visibility During Endoscopy: A Randomized Controlled Trial
Journal of Gastroenterology and Hepatology · 2026-06 · 41 (6) · 1874-1882
DOI: 10.1111/jgh.70392 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Gastroenterology and Hepatology, online erschienen am 10.04.2026. Verfasst von Zaheer Nabi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Asian Institute of Gastroenterology, Hyderabad, India. Hauptthemen laut MEDLINE: Gastric Mucosa, Premedication, Simethicone, Acetylcysteine. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 22 Literaturangaben.
Abstract (Originalsprache)
Background
Adequate gastric mucosal visibility (GMV) is essential for high quality upper gastrointestinal (GI) endoscopy. Simethicone and N‐acetylcysteine (NAC) are commonly used to improve mucosal visibility, but the optimal timing of administration remains uncertain.
Objective
This double‐blinded randomized controlled trial (RCT) evaluated the optimal interval between premedication (simethicone + NAC) and endoscopy for achieving adequate GMV.
Design
In this RCT, adults undergoing elective upper GI endoscopy were randomized to four groups: placebo (Group 1), premedication to endoscopy interval of 10–20 (Group 2), 21–30 (Group 3), or > 30 min (Group 4). GMV was scored in four gastric regions (antrum, distal body, proximal body, fundus) on a 4‐point scale (range 4–16). The primary outcome was adequate GMV (total score < 7). Secondary outcomes included median total GMV score, region‐wise mucosal visibility scores, lesion detection rate, and predictors of adequate GMV.
Results
A total of 1200 adults were randomized to four groups. Adequate GMV was significantly more frequent in Groups 3 (64.7%) and 4 (66.7%) than in placebo (2.7%) or Group 2 (25.0%). Subgroup analysis within Group 4 demonstrated a declining trend after 50 min. ROC analysis suggested an optimal cut‐off of 25 min in predicting adequate GMV with area under the curve of 0.80. In region‐wise analysis, mean visibility scores were lowest in antrum and distal body. There was no significant difference in the detection of gastric lesions across study groups ( p = 0.913). No serious adverse events related to premedication were observed.
Conclusion
Premedication with simethicone and NAC significantly improves GMV. The improvement becomes optimal at 20–30 min after ingestion and is consistently maintained up to 50 min. Trial Registration: ClinicalTrials.gov identifier: NCT06581783
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Asian Institute of Gastroenterology, Hyderabad, India.
ORCID-Profile: Mahiboob Sayyed, Aniruddha Pratap Singh, Pradev Inavolu
Zitieren
APA
Nabi, Z., Dasireddy, P. S., Sayyed, M., Reddy, P., Goud, R., Rughwani, H., Singh, A. P., Inavolu, P., Reddy, P. M., Basha, J., Gupta, R., Tandan, M., & Reddy, D. N. (2026). Impact of Timing of Premedication on Mucosal Visibility During Endoscopy: A Randomized Controlled Trial. Journal of Gastroenterology and Hepatology, 41(6), 1874-1882. https://doi.org/10.1111/jgh.70392
Vancouver
Nabi Z, Dasireddy PS, Sayyed M, Reddy P, Goud R, Rughwani H, et al. Impact of Timing of Premedication on Mucosal Visibility During Endoscopy: A Randomized Controlled Trial. Journal of Gastroenterology and Hepatology. 2026;41(6):1874-1882. doi:10.1111/jgh.70392
BibTeX
@article{Nabi2026,
author = {Nabi, Zaheer and Dasireddy, Preethi Sudha and Sayyed, Mahiboob and Reddy, Praveen and Goud, Rajesh and Rughwani, Hardik and Singh, Aniruddha Pratap and Inavolu, Pradev and Reddy, Palle Manohar and Basha, Jahangeer and Gupta, Rajesh and Tandan, Manu and Reddy, D Nageshwar},
title = {Impact of Timing of Premedication on Mucosal Visibility During Endoscopy: A Randomized Controlled Trial},
journal = {Journal of Gastroenterology and Hepatology},
year = {2026},
volume = {41},
number = {6},
pages = {1874--1882},
doi = {10.1111/jgh.70392}
}
EUVIMED